Introduction
A variety of immunoregulatory polypeptides have been implicated as modulators of endocrine and neuroendocrine secretions (Rothwell, 1991a) . Most notable are the cytokines, particularly interleukin (IL)-l, and tumour necrosis factor (TNF-). While much work has focused on the interaction between the immune system and the adrenal axis, there is growing evidence that suggests that cytokines can modulate reproductive functions. Several studies have shown that IL-1, and TNF-inhibit steroidogenesis in ovarian follicles and suppress the functional and morphological luteinization of cultured granulosa cells (Adashi, 1990) . Direct (Beach et al, 1989; Spangelo et al, 1989; Yamaguchi et al, 1990a) . In contrast, parallel in vivo and in vitro experiments (Rivier and Vale, 1990; Kalra et al, 1990) suggest that inhibits the release of LH by suppressing the secretion of GnRH. Although these experiments demonstrate pharmacological effects of IL-1, and TNF-on the secretion of reproductive hormones, little is known about the response of the reproduc¬ tive system to an infection. Macrophages and monocytes release IL-iß and TNF-when challenged with a bacterial endotoxin such as lipopolysaccharide (Raetz et al, 1991) and IL-iß can stimulate the release of IL-6 from pituitary cells (Spangelo et al, 1991) . Furthermore, there is evidence that the brain (Rothwell, 1991b) and pituitary gland (Koenig et al, 1990) are sites of IL-lß and IL-6 production. On (Welschen and Rutte, 1971 (Fig. 2a, b) , while the low dose LPS treatment (20 pg kg~*) resulted in a significant attenuation of the primed LH response (Fig. 2a) (Fig. 4a, b) . In contrast, when LPS was added to the culture medium, no significant attenuation of GnRH-stimulated LH (Fig. 5a, b) . However, high doses of CS (10 pg and 100 pg ml-1) did attenuate LH responses to GnRH, but only when the drug was added to the medium at the beginning of the culture period (Fig. 6a, b) . CS did not affect LH responses when it was added only at the same time as the GnRH stimulus (Fig. 6a) (Rivier and Vale, 1990) and to attenuate the positive feedback effects of steroids in ovariectomized rats (Kalra et al, 1990) through a hypothalamic site of action rather than a direct action on the pituitary gland. Rivier and Vale (1990) also showed that intracerebroventricular injections of TNF-suppressed LH release, but the potency of this cytokine was far less than that of IL-lß. In contrast, IL-1 (Beach et al, 1989) , (Spangelo et al, 1989) and TNF- (Yamaguchi et al, 1990a) (Vankelecom el al, 1984; Yamaguchi el al, 1990b) . Since endotoxin can stimulate the synthesis of IL-lß both in the brain (Rothwell, 1991b) and pituitary gland (Koenig et al, 1990) , it would be anticipated that the LPS treatment could lead to disturbed regulation of gonadotrophin secretion. Indeed, intracerebroventricular administration of 2 pg LPS inhibits LH release in castrated male rats (Rivier, 1990) the morning of pro-oestrus (Rivier and Vale, 1990) . However, a single intraperitoneal injection of LPS (25 pg) at pro-oestrus did not affect ovulation the following day and Rivier and Vale concluded that high concentrations of IL-1 in the brain were required to inhibit ovulation (Rivier and Vale, 1990 (Brann and Mahesh, 1991 (Gottschall el al, 1988; Fukuoka et al, 1989; Andreani et al, 1991; Hurwitz et al, 1991a) , although in intact ovarian follicles TNF-has been shown to stimulate steroidogenesis (Roby and Terranova, 1990 ).
Since there are resident macrophages within the ovary and the ovary has been shown to be a site of both IL-lß (Hurwitz Mandi and Zuckerman (1952 (Adashi, 1990, Roby and Terranova, 1990 (Bagavandoss et al, 1988 (Bagavandoss et al, , 1990 (Al-Chalabi, 1984; Sikka et al, 1988) 
